Provectus Biopharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of PVCT for the last quarter is 109.75 k USD, and it's 56.96% lower compared to the previous quarter. The net income of Q3 24 is -1.01 M USD.